Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 June 2023 | Story Kamohelo Tshabalala | Photo Supplied
Dr  Kamohelo Tshabalala
Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics, shares his UFS journey.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics, shares his UFS journey:

Q: Year of graduation from the UFS: 

A: 2004 and 2015.

Q: Qualification obtained from the UFS: 

A: BSc in Physics and Mathematics and PhD in Solid State Physics.

Q: Date of joining the UFS as a staff member: 

A: 2003 to 2004 and 2012 to date.

Q: Initial job title and current job title: 

A: I began my journey as a Lab Assistant, but over time, I advanced to higher positions within the academic realm. Presently, I proudly serve as a Senior Lecturer and Subject Head in the esteemed Department of Physics. Additionally, I have taken on the role of acting Assistant Dean in the distinguished Faculty of Natural and Agricultural Sciences.

Q: How did the UFS prepare you for the professional world? 

A: First and foremost, I successfully completed my BSc degree, followed by the attainment of a Doctor of Philosophy (PhD). I firmly believe that these educational achievements serve as a solid foundation for excelling in both teaching and leadership roles.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member? 

A: It is a very interesting aspect; however, this transition may entirely depend on an individual’s interest in whether to continue with their studies or not. The stimulation may come from the undergraduate teachings that exhibit real interventions for new developments towards empowering the society at large.

Q: Any additional comments about your experience? 
A: As both an academic and a departmental leader for the past nine years, I am very grateful for all the support from the university community. I would encourage young scholars to explore more leadership roles that are available in the sector, because one is always up to date with new initiatives and strategies for the betterment of human and academic projects.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept